Tradestie Institutional Equity Comparison Engine

GNTA vs DSCO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

GNTA Overall Edge

GNTA Captures Institutional Edge (1โ€“1 Pillars ยท 6โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Genenta Science S.p.A. American Depositary Shares (GNTA) driven by superior Growth & Margin while DSCO counters with relative strength in Momentum & Technical. Fundamentally, GNTA trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus DSCO at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, GNTA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against DSCO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
GNTA N/M vs DSCO N/M Fwd P/E
Growth & Margin Winner GNTA
Op Margin 0.0% vs N/A ยท YoY +0.0% vs N/A
Momentum & Technical Winner DSCO
1Y -61.7% vs -3.0% ยท 52W Pos 18% vs 14%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
GNTA NASDAQ
Genenta Science S.p.A. American Depositary Shares
Biological Products, (No Diagnostic Substances)
$0.98
+20.62% 1D
Market Cap $39.4M
1M Return +34.93%
1Y Return -61.67%
Forward P/E N/M
Unified AI Score
35.3 / 100 SELL
Tech 15.0 Fund 36.0 Flow 50.0 Mom 40.0
DSCO US Equity
DSCO
Institutional Equity
$24.29
-0.21% 1D
Market Cap N/A
1M Return -0.33%
1Y Return -2.98%
Forward P/E N/M
Unified AI Score
39.5 / 100 SELL
Tech 32.0 Fund 50.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: GNTA -61.67% DSCO -2.98% Spread: +2.59 pp (GNTA Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
GNTA TTM Op. Margin: 0.0% DSCO TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GNTA vs DSCO. Trailing 12-month operating profitability (GNTA 0.0% vs DSCO N/A) and valuation multiples (GNTA N/M vs DSCO N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: GNTA (6) vs DSCO (2)
Institutional Metric GNTA DSCO Criterion Row Winner
Market Capitalization Scale $39.4M N/A Larger Scale GNTA
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% N/A Higher Growth GNTA
Operating Margin (TTM) Profitability 0.0% N/A Higher Margin GNTA
Net Profit Margin Profitability 0.0% N/A Higher Margin GNTA
Return on Equity (ROE) Capital Efficiency -38.0% N/A Higher ROE GNTA
52-Week Range Position Momentum 18% ($1โ€“$3) 14% ($24โ€“$25) Stronger Trend GNTA
Beta / 30D Volatility Risk Regime 1.45ฮฒ ยท 132% Vol 0.03ฮฒ ยท 2% Vol Lower Realized Risk DSCO
Unified Institutional Score Composite Signal 35.3 / 100 (SELL) 39.5 / 100 (SELL) Higher Composite DSCO

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full GNTA vs DSCO Buy Guide
GNTA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live GNTA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
DSCO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live DSCO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither GNTA nor DSCO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.